Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2026-01-17 @ 12:48 AM
Study NCT ID:
NCT02199132
Status:
COMPLETED
Last Update Posted:
2015-08-03
First Post:
2014-07-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli
Sponsor:
Corporacion Parc Tauli
Organization:
Study Overview
Official Title:
Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli
Status:
COMPLETED
Status Verified Date:
2015-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Retrospective study of patients diagnosed with a nasopharyngeal carcinoma included in our data base care between June 1990 and September 2013.
Our hypothesis is:
Our series of patients with a history of nasopharyngeal carcinoma presents epidemiological, response rates to the different treatments and survival similar to those described in the literature
Our hypothesis is:
Our series of patients with a history of nasopharyngeal carcinoma presents epidemiological, response rates to the different treatments and survival similar to those described in the literature
Detailed Description:
Retrospective study of 50 patients diagnosed with nasopharyngeal carcinoma. The following variables will be studied: age, sex, toxic habits , associated pathology, patient origin , first symptom , duration , histology, stage , second malignancies , recurrences , metastases , treatments performed , the response thereto and survival.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: